Search results
- 174.32Add to watchlist+1.47 (+0.85%)At close:4:00 PM EDTMon. May 20, 2024174.32 0.00 (0.00%)After hrs:4:00 PM EDTMon. May 20, 2024Nasdaq Real Time Price (USD) · Market closed
- Open172.83High175.63Low171.81
- Mkt Cap19.77BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close172.8552 Wk. Low126.9752 Wk. High244.55
Top storiesThe BeiGene, Ltd. (NASDAQ:BGNE) First-Quarter Results Are Out And Analysts Have Published New ForecastsYahoo Finance · 1 week agoDecoding BeiGene Ltd (BGNE): A Strategic SWOT InsightYahoo Finance · 2 weeks agoBeiGene First Quarter 2024 Earnings: Beats ExpectationsYahoo Finance · 2 weeks agoRelated stocks
Find the latest BeiGene, Ltd. (BGNE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Get the latest stock price, news, and insights for BGNE, a biotechnology company developing cancer therapies. Nasdaq provides real-time data, cloud-based analytics, and data link services for BGNE.
4 days ago · BeiGene is a global oncology company that develops and commercializes innovative medicines for cancer. Get the latest stock price, news, earnings, analyst ratings, and more for BGNE.
- 14.22B
- 2.46B
- 881.71M
- 108.60M
People also ask
What does bgne stand for?
What is benchmark bgne (bgne)?
Where is bgne headquartered?
Does bgne pay a dividend?
May 14, 2024 · BeiGene is a biopharmaceutical company that develops and commercializes innovative and affordable medicines for cancer patients worldwide. Learn more about its product portfolio, vision, and resources for patients.
4 days ago · A high-level overview of BeiGene, Ltd. (BGNE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Get the latest Beigene Ltd (BGNE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
May 13, 2024 · BeiGene Ltd. is a Chinese biotech company that develops and commercializes cancer drugs. Get the latest stock price, performance, analyst ratings, news and more on MarketWatch.